Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

MLA

Levy, G., et al. “Improved Clinical Outcomes for Liver Transplant Recipients Using Cyclosporine Monitoring Based on 2-Hr Post-Dose Levels (C2).” Transplantation, vol. 73, no. 6, Mar. 2002, pp. 953–59. EBSCOhost, https://doi.org/10.1097/00007890-200203270-00022.

APA

Levy, G., Burra, P., Cavallari, A., Duvoux, C., Lake, J., Mayer, A. D., Mies, S., Pollard, S. G., Varo, E., Villamil, F., & Johnston, A. (2002). Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation, 73(6), 953–959. https://doi.org/10.1097/00007890-200203270-00022

Chicago

Levy, G, P Burra, A Cavallari, C Duvoux, J Lake, A D Mayer, S Mies, et al. 2002. “Improved Clinical Outcomes for Liver Transplant Recipients Using Cyclosporine Monitoring Based on 2-Hr Post-Dose Levels (C2).” Transplantation 73 (6): 953–59. doi:10.1097/00007890-200203270-00022.